FDA Office of Hematology Oncology Products Reorganizes, Renamed Office
Office Renaming
Related Articles
Types of Cancer Treatment
This page lists the different cancer treatments, including chemotherapy, radiation therapy, immunotherapy, and targeted therapy and takes you to more information about each type.
Bench to Bedside Chat- “Drug Development for Economically Infeasible Indications”
This video discusses FDA programs that are designed to support rare disease product development.
FDA approves retifanlimab-dlwr with carboplatin and paclitaxel and as
FDA approves retifanlimab-dlwr with carboplatin and paclitaxel and as a single agent for squamous cell carcinoma of the anal canal
FDA approves retifanlimab-dlwr with carboplatin and paclitaxel and as
FDA approves retifanlimab-dlwr with carboplatin and paclitaxel and as a single agent for squamous cell carcinoma of the anal canal
Childhood Cancers
Information about the common types of pediatric cancers, the latest treatments, where to go for treatment, and where to find information about coping and survivorship.
FDA approves belzutifan for pheochromocytoma or paraganglioma
On May 14, 2025, the Food and Drug Administration approved belzutifan (Welireg, Merck & Co., Inc.) for adult and pediatric patients 12 years and older
FDA approves belzutifan for pheochromocytoma or paraganglioma
On May 14, 2025, the Food and Drug Administration approved belzutifan (Welireg, Merck & Co., Inc.) for adult and pediatric patients 12 years and older
FDA approves belzutifan for pheochromocytoma or paraganglioma
On May 14, 2025, the Food and Drug Administration approved belzutifan (Welireg, Merck & Co., Inc.) for adult and pediatric patients 12 years and older
Bench to Bedside Chat- “Drug Development for Economically Infeasible Indications”
This video discusses FDA programs that are designed to support rare disease product development.
Metastatic Cancer: When Cancer Spreads
Metastatic cancer is cancer that spreads from its site of origin to another part of the body. Learn how cancer spreads, possible symptoms, common sites…